FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 15 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $49,556 | -22.9% | 107,731 | -16.6% | 0.01% | -77.4% |
Q4 2022 | $64,313 | -30.1% | 129,169 | -2.1% | 0.06% | -26.2% |
Q3 2022 | $92,000 | -28.7% | 131,957 | -10.0% | 0.08% | -14.3% |
Q2 2022 | $129,000 | -20.4% | 146,562 | +1.3% | 0.10% | +28.9% |
Q1 2022 | $162,000 | -55.0% | 144,672 | -20.7% | 0.08% | -42.0% |
Q4 2021 | $360,000 | – | 182,521 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,379,843 | $11,246,000 | 2.62% |
Novo Holdings A/S | 2,361,229 | $19,244,000 | 0.85% |
Ally Bridge Group (NY) LLC | 401,747 | $3,274,000 | 0.81% |
SECTORAL ASSET MANAGEMENT INC | 640,714 | $5,222,000 | 0.42% |
FRAZIER MANAGEMENT LLC | 550,000 | $4,483,000 | 0.41% |
TFG Asset Management GP Ltd | 750,000 | $6,113,000 | 0.33% |
Eventide Asset Management | 2,485,656 | $19,757,000 | 0.26% |
AXA S.A. | 1,111,510 | $9,058,000 | 0.01% |
Woodline Partners LP | 25,932 | $211,000 | 0.00% |
WELLINGTON MANAGEMENT GROUP LLP | 2,001,951 | $16,315,000 | 0.00% |